Viewing Study NCT03216759


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-03 @ 6:48 PM
Study NCT ID: NCT03216759
Status: UNKNOWN
Last Update Posted: 2017-07-13
First Post: 2017-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications
Sponsor: Nanfang Hospital, Southern Medical University
Organization:

Study Overview

Official Title: Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications in Patients Undergoing Laparotomy With General Anesthesia
Status: UNKNOWN
Status Verified Date: 2017-07
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CIPS
Brief Summary: To investigate the morbidity of intestinal injury after open surgery and observe the effect of comprehensive intestinal protection strategy on postoperative intestinal complications in patients undergoing laparotomy with general anesthesia.
Detailed Description: Perioperative intestinal injury is one of the common tissues and organs injury in surgical practice. However, there is a lack of effective means of prevention and treatment.The investigators previously found that ischemic preconditioning, IPC, and dexmedetomidine has protective effects on intestinal mucosal injury.

However, the combined effect of various factors has not been clinically validated. To explore the effect of comprehensive intestinal protection strategy on postoperative intestinal complications in patients undergoing laparotomy with general anesthesia,the investigators select the patients undergoing open surgery under general anesthesia as the study subjects and the concentration of intestinal fatty acid binding protein (I-FABP) as well as the incidence of digestive system complications in one week after operation are the main observation indexes.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: